Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nadroparin calcium versus heparin anticoagulation in hemoperfusion
ChiCTR2000034074Phase 4Recruiting
- Sponsor
- Affiliated Hospital of Nantong University
- Start
- Jun 2020
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised trial of nadroparin in conditions requiring hemoperfusion (3 arms), sponsored by Affiliated Hospital of Nantong University. Primary endpoint: platelet count. Started Jun 2020; status: recruiting.
02
Drugs
nadroparin
03
Conditions
conditions requiring hemoperfusion
Beyond the preview
Go deeper on ChiCTR2000034074.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000034074.